NewsEpisurf Medical receives market approval in Israel and signs distribution agreement for the Israeli market

Episurf Medical (NASDAQ: EPIS B) today announces that the Israeli Ministry of Health has approved Episurf Medical’s Episealer® knee products for the Israeli market. The approval follows a review process. Episurf Medical further announces that the company has entered into a distribution agreement for the Israeli market with AMI Technologies Ltd., a leading distributor of medical devices in Israel.

“We are very happy to continue executing on our global strategy by opening up our first distribution market. This is an important step for Episurf Medical” says Pål Ryfors, CEO Episurf Medical.

For more  information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com